Table 23.
Pharmacokinetic parameter | VGL |
VRH |
||||
---|---|---|---|---|---|---|
0.61 mg/kg | 1.22 mg/kg | 2.45 mg/kg | 1.40 mg/kg | 2.80 mg/kg | 5.60 mg/kg | |
t1/2 α (h) | 0.028 ± 0.002 | 0.029 ± 0.006 | 0.031 ± 0.003 | 0.029 ± 0.002 | 0.03 ± 0.005 | 0.033 ± 0.004 |
t1/2 β (h) | 0.251 ± 0.004 | 0.25 ± 0.037 | 0.265 ± 0.006 | 0.25 ± 0.01 | 0.246 ± 0.035 | 0.26 ± 0.006 |
Half-life of elimination phase (t1/2 γ) (h) | 2.671 ± 0.087 | 2.416 ± 0.137 | 2.373 ± 0.068 | 2.325 ± 0.163 | 2.273 ± 0.095 | 2.176 ± 0.051 |
Apparent volumes of distribution of the central compartments (V1) (L/kg) | 0.021 ± 0.004 | 0.024 ± 0.01 | 0.024 ± 0.005 | 0.020 ± 0.006 | 0.022 ± 0.008 | 0.022 ± 0.003 |
CL (L/h/kg) | 0.096 ± 0.013 | 0.101 ± 0.014 | 0.097 ± 0.010 | 0.094 ± 0.01 | 0.0932 ± 0.013 | 0.089 ± 0.01 |
AUC(0−t) (mg h/L) | 4.492 ± 0.54 | 9.337 ± 1.215 | 20.891 ± 2.489 | 10.892 ± 1.168 | 23.766 ± 3.447 | 51.71 ± 6.504 |
AUC(0−∞) (mg h/L) | 5.60 ± 0.778 | 10.578 ± 1.507 | 21.605 ± 2.459 | 12.664 ± 1.387 | 26.324 ± 4.238 | 53.984 ± 6.615 |
MRT(0−t) (h) | 1.268 ± 0. | 1.478 ± 0.032 | 1.73 ± 0.018 | 1.212 ± 0.016 | 1.45 ± 0.05 | 1.668 ± 0.012 |
MRT(0−∞) (h) | 2.543 ± 0.225 013 | 2.269 ± 0.096 | 2.18 ± 0.054 | 2.123 ± 0.215 | 2.142 ± 0.108 | 2.11 ± 0.071 |
AUC = area under the concentration-time curve; MRT = mean residence time.